Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Jun 05, 2024

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Nextdoor Holdings Inc (Class A)	Jason Pressman	Director		05 Jun 2024	5,000,000	5,000,000	-		0	Class A Common Stock
Nextdoor Holdings Inc (Class A)	Jason Pressman	Director		05 Jun 2024	5,000,000	18,360,232	-		-	Class B Common Stock
Nextdoor Holdings Inc (Class A)	Jason Pressman	Director	Other type of transaction at price $ 0.00 per share.	05 Jun 2024	5,000,000	0	-		-	Class A Common Stock
Adicet Bio Inc	Chen Schor	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	1,770,427	1,770,427	-		-	Stock Option (Right to Buy)
Vertex Inc (Class A)	Jeffrey Westphal	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 32.93 per share.	05 Jun 2024	1,500,000	2,554,641	-	32.9	49,395,000	Class A Common Stock
Cava Grp Inc	Ronald M. Shaich	Director	Sale of securities on an exchange or to another person at price $ 87.25 per share.	05 Jun 2024	1,231,979	5,000	-	87.3	107,490,168	Common Stock
DarioHealth Corp	Steven Nelson	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	1,200,000	1,350,000	-		-	Stock Option (right to buy)
Nextdoor Holdings Inc (Class A)	Jason Pressman	Director	Other type of transaction at price $ 0.00 per share.	05 Jun 2024	1,040,000	1,060,000	-		-	Class A Common Stock
T-Mobile US Results Board Meeting	Marcelo Claure	Director	Sale of securities on an exchange or to another person at price $ 179.98 per share.	05 Jun 2024	1,037,622	1,962,378 (0%)	0%	180.0	186,751,208	Common Stock
Nextdoor Holdings Inc (Class A)	Jason Pressman	Director	Other type of transaction at price $ 0.00 per share.	05 Jun 2024	1,015,000	45,000	-		-	Class A Common Stock
T-Mobile US Results Board Meeting	Marcelo Claure	Director	Sale of securities on an exchange or to another person at price $ 180.20 per share.	05 Jun 2024	1,000,000	3,000,000 (0%)	0%	180.2	180,200,000	Common Stock
T-Mobile US Results Board Meeting	Marcelo Claure	Director	Sale of securities on an exchange or to another person at price $ 179.87 per share.	05 Jun 2024	1,000,000	4,000,000 (0%)	0%	179.9	179,870,000	Common Stock
BeiGene Ltd (ADR)	John V. Oyler	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	923,975	923,975	-		-	Share Option (Right to Buy)
ElectroCore Inc	Charles S. Theofilos	Director		05 Jun 2024	770,119	770,119	-		-	Prefunded Common Stock Warrants (right to buy)
Cava Grp Inc	Ronald M. Shaich	Director	Sale of securities on an exchange or to another person at price $ 87.25 per share.	05 Jun 2024	664,834	0	-	87.3	58,006,767	Common Stock
Cava Grp Inc	Ronald M. Shaich	Director	Sale of securities on an exchange or to another person at price $ 87.25 per share.	05 Jun 2024	653,477	0	-	87.2	57,015,868	Common Stock
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Adam M. Aron	Director, PRESIDENT, CEO & CHAIRMAN	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	631,579	631,579	-		-	RESTRICTED STOCK UNITS
Invivyd Inc	Timothy Lee	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	600,000	600,000	-		-	Stock Option (Right to Buy)
Upland Software Inc	John T. Mcdonald	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	500,000	750,000	-		-	Performance Share Unit
DarioHealth Corp	Steven Nelson	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	500,000	500,000	-		-	Stock Option (right to buy)
BeiGene Ltd (ADR)	John V. Oyler	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	490,464	1,812,018 (0%)	0%		0	Ordinary Shares
BeiGene Ltd (ADR)	Xiaobin Wu	President, COO & GM China	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	477,386	477,386	-		-	Share Option (Right to Buy)
Lucid Grp Inc	Peter Rawlinson	Director, CEO & Chief Technology Officer		05 Jun 2024	476,262	19,006,903	-	2.9	1,357,347	Class A Common Stock
Karyopharm Therapeutics Inc	Deepika Rachel Pakianathan	Director	Sale of securities on an exchange or to another person at price $ 0.96 per share.	05 Jun 2024	463,518	346,615 (0%)	0%	1.0	444,143	Common Stock
BeiGene Ltd (ADR)	Xiaodong Wang	Director, Chair, Scientific Advisory Brd	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	410,657	410,657	-		-	Share Option (Right to Buy)
Priority Technology Holdings	Ranjana Ram	Chief Operating Officer	Other type of transaction at price $ 0.00 per share.	05 Jun 2024	408,013	788,782 (1%)	0%		-	Common Stock
DarioHealth Corp	Steven Nelson	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	400,000	400,000	-		-	Stock Option (right to buy)
ElectroCore Inc	Charles S. Theofilos	Director		05 Jun 2024	385,059	385,059	-		-	Common Stock Warrants (right to buy)
Adicet Bio Inc	Francesco Galimi	SVP & Chief Medical Officer		05 Jun 2024	375,077	375,077	-		-	Stock Option (Right to Buy)
AVITA Medical Inc	James M. Corbett	Director, CEO		05 Jun 2024	350,000	350,000	-		-	Stock Options (Right to Buy)
Adicet Bio Inc	Blake Aftab	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	336,911	336,911	-		-	Stock Option (Right to Buy)
BeiGene Ltd (ADR)	Lai Wang	Global Head of R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	318,253	318,253	-		-	Share Option (Right to Buy)
Adicet Bio Inc	Donald Healey	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	271,595	271,595	-		-	Stock Option (Right to Buy)
BeiGene Ltd (ADR)	Julia Wang	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	256,659	256,659	-		-	Share Option (Right to Buy)
BeiGene Ltd (ADR)	Xiaobin Wu	President, COO & GM China	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	253,409	1,268,849 (0%)	0%		0	Ordinary Shares
Prime Medicine Inc	Keith Gottesdiener	Director, See Remarks		05 Jun 2024	250,000	277,166	-		0	Common Stock
Prime Medicine Inc	Keith Gottesdiener	Director, See Remarks		05 Jun 2024	250,000	2,310,837	-		0	Common Stock
Grindr Inc (Class A)	James Fu Bin Lu	Director, Ten Percent Owner		05 Jun 2024	230,273	36,660,429	-	9.3	2,141,930	Common Stock
Karyopharm Therapeutics Inc	Deepika Rachel Pakianathan	Director	Sale of securities on an exchange or to another person at price $ 0.95 per share.	05 Jun 2024	229,308	0 (0%)	0%	1.0	218,003	Common Stock
Nextdoor Holdings Inc (Class A)	Jason Pressman	Director	Other type of transaction at price $ 0.00 per share.	05 Jun 2024	219,490	546,170	-		-	Class A Common Stock
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Sean D. Goodman	EVP, CFO & TREASURER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	210,527	210,527	-		-	RESTRICTED STOCK UNITS
Grindr Inc (Class A)	James Fu Bin Lu	Director, Ten Percent Owner		05 Jun 2024	207,870	36,890,702	-	9.2	1,921,197	Common Stock
Allogene Therapeutics Inc	Joshua A. Kazam	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	191,082	191,082	-		-	Stock Option (Right to buy)
Allogene Therapeutics Inc	Owen N. Witte	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	191,082	191,082	-		-	Stock Option (Right to buy)
Allogene Therapeutics Inc	Elizabeth Barrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	191,082	191,082	-		-	Stock Option (Right to buy)
Allogene Therapeutics Inc	Stephen L. Mayo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	191,082	191,082	-		-	Stock Option (Right to buy)
BeiGene Ltd (ADR)	Chan Henry Lee	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	184,795	184,795	-		-	Share Option (Right to Buy)
Dynatrace Inc	Rick M. Mcconnell	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	176,896	856,058 (0%)	0%		0	Common Stock
BeiGene Ltd (ADR)	Lai Wang	Global Head of R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	168,935	1,768,962 (0%)	0%		0	Ordinary Shares
GEN Restaurant Grp Inc (Class A)	Wook Jin David Kim	Director, Co-Chief Executive Officer, Ten Percent Owner	Other type of transaction at price $ 6.05 per share.	05 Jun 2024	158,652	158,652	-	6.1	959,845	Class A Common Stock
Cue Biopharma Inc	Anish Suri	PRESIDENT AND CSO		05 Jun 2024	150,000	150,000	-		-	Stock Option (right to buy)
Sweetgreen Inc (Class A) High Gain High Volume	Jonathan Neman	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.96 per share.	05 Jun 2024	150,000	2,250,000	-	1.0	144,000	Class A Common Stock
Sweetgreen Inc (Class A) High Gain High Volume	Jonathan Neman	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	150,000	125,000	-		-	Stock Option (Right to Buy)
Sweetgreen Inc (Class A) High Gain High Volume	Jonathan Neman	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 30.50 per share.	05 Jun 2024	150,000	2,100,000	-	30.5	4,575,000	Class A Common Stock
Sweetgreen Inc (Class A) High Gain High Volume	Nicolas Jammet	Director, Chief Concept Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.96 per share.	05 Jun 2024	150,000	2,250,000	-	1.0	144,000	Class A Common Stock
Sweetgreen Inc (Class A) High Gain High Volume	Nicolas Jammet	Director, Chief Concept Officer	Sale of securities on an exchange or to another person at price $ 30.50 per share.	05 Jun 2024	150,000	2,100,000	-	30.5	4,575,000	Class A Common Stock
Sweetgreen Inc (Class A) High Gain High Volume	Nicolas Jammet	Director, Chief Concept Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	150,000	125,000	-		-	Stock Option (Right to Buy)
Sweetgreen Inc (Class A) High Gain High Volume	Nathaniel Ru	Director, Chief Brand Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.96 per share.	05 Jun 2024	150,000	2,271,899	-	1.0	144,000	Class A Common Stock
Sweetgreen Inc (Class A) High Gain High Volume	Nathaniel Ru	Director, Chief Brand Officer	Sale of securities on an exchange or to another person at price $ 30.50 per share.	05 Jun 2024	150,000	2,121,899	-	30.5	4,575,000	Class A Common Stock
Sweetgreen Inc (Class A) High Gain High Volume	Nathaniel Ru	Director, Chief Brand Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	150,000	125,000	-		-	Stock Option (Right to Buy)
iHeartMedia Inc (Class A) New	Cheryl D. Mills	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	145,631	249,575 (0%)	0%		0	Class A Common Stock, par value $0.001 per share
iHeartMedia Inc (Class A) New	James A. Rasulo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	145,631	379,545 (0%)	0%		0	Class A Common Stock, par value $0.001 per share
iHeartMedia Inc (Class A) New	Bradley T. Gerstner	Director		05 Jun 2024	145,631	461,867 (0%)	0%		0	Class A Common Stock, par value $0.001 per share
iHeartMedia Inc (Class A) New	Bradley T. Gerstner	Director		05 Jun 2024	145,631	316,236 (0%)	0%	1.0	150,000	Class A Common Stock, par value $0.001 per share
iHeartMedia Inc (Class A) New	Graciela I. Monteagudo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	145,631	225,242 (0%)	0%		0	Class A Common Stock, par value $0.001 per share
iHeartMedia Inc (Class A) New	Kamakshi Sivaramakrishnan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	145,631	263,961 (0%)	0%		0	Class A Common Stock, par value $0.001 per share
iHeartMedia Inc (Class A) New	Samuel E. Englebardt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	145,631	411,766 (0%)	0%		0	Class A Common Stock, par value $0.001 per share
iHeartMedia Inc (Class A) New	Samuel E. Englebardt	Director	Grant, award, or other acquisition of securities at price $ 1.03 per share.	05 Jun 2024	145,631	266,135 (0%)	0%	1.0	150,000	Class A Common Stock, par value $0.001 per share
Offerpad Soln Inc (Class A)	Peter Knag	Chief Financial Officer		05 Jun 2024	145,000	145,000	-		0	Class A Common Stock
HF Foods Grp Inc	Xiao Mou Zhang	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 3.55 per share.	05 Jun 2024	142,606	3,134,091 (6%)	0%	3.5	506,251	Common Stock
BeiGene Ltd (ADR)	Julia Wang	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	136,240	456,326 (0%)	0%		0	Ordinary Shares
Cue Biopharma Inc	Matteo Levisetti	Chief Medical Officer		05 Jun 2024	125,000	125,000	-		-	Stock Option (right to buy)
NovoCure Ltd Results Board Meeting	Wilhelmus C. M. Groenhuysen	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	124,373	95,000	-		-	Stock Options (Right to buy)
NovoCure Ltd Results Board Meeting	Wilhelmus C. M. Groenhuysen	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.82 per share.	05 Jun 2024	124,373	124,373 (0%)	0%	22.8	2,838,192	Ordinary Shares
InnovAge Holding Corp	Patrick Blair	PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	123,967	631,175	-		0	Common Stock, $0.001 par value
Allogene Therapeutics Inc	Deborah M. Messemer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	122,950	185,406 (0%)	0%		0	Common Stock
Karyopharm Therapeutics Inc	Deepika Rachel Pakianathan	Director	Sale of securities on an exchange or to another person at price $ 0.98 per share.	05 Jun 2024	117,307	229,308 (0%)	0%	1.0	115,289	Common Stock
BeiGene Ltd (ADR)	Xiaodong Wang	Director, Chair, Scientific Advisory Brd	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	108,992	5,568,430 (0%)	0%		0	Ordinary Shares
W & T Offshore Inc	Tracy W. Krohn	Chairman, CEO & President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	106,666	213,334	-		-	Restricted Stock Units
W & T Offshore Inc	Tracy W. Krohn	Chairman, CEO & President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	106,666	623,599 (0%)	0%		-	Common Stock
D-Wave Quantum Inc	Emil Michael	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	106,626	993,674	-		0	Common Stock, par value $0.0001 per share ("Common Stock")
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Daniel E. Ellis	EVP, CHIEF OPS & DEV OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	105,264	105,264	-		-	RESTRICTED STOCK UNITS
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Elizabeth F. Frank	EVP, CONT & WW PROG OFF		05 Jun 2024	105,264	105,264	-		-	RESTRICTED STOCK UNITS
SoundHound AI Inc (Class A)	Timothy Stonehocker	Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 5.00 per share.	05 Jun 2024	104,000	883,570	-	5.0	520,094	Class A Common Stock
Ardelyx Inc	Laura Williams	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	100,000	251,000	-		-	Stock Option (Right to Buy)
Ardelyx Inc	Laura Williams	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 7.12 per share.	05 Jun 2024	100,000	322,152 (0%)	0%	7.1	712,500	Common Stock
Ardelyx Inc	Laura Williams	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.75 per share.	05 Jun 2024	100,000	467,152 (0%)	0%	2.8	275,000	Common Stock
Compass Inc (Class A)	Kalani Reelitz	Chief Financial Officer		05 Jun 2024	100,000	482,860	-		0	Class A Common Stock
Compass Inc (Class A)	Kalani Reelitz	Chief Financial Officer		05 Jun 2024	100,000	1,000,000	-		-	Restricted Stock Unit (RSU)
Recursion Pharma Inc (Class A)	Christopher Gibson	Director, Chief Executive Officer		05 Jun 2024	100,000	6,326,700	-		-	Class B Common Stock
Recursion Pharma Inc (Class A)	Christopher Gibson	Director, Chief Executive Officer		05 Jun 2024	100,000	908,738	-		0	Class A Common Stock
OppFi Inc (Class A)	David Vennettilli	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	05 Jun 2024	100,000	44,238	-		0	Class V Common Stock
OppFi Inc (Class A)	David Vennettilli	Director	Sale of securities on an exchange or to another person at price $ 6.45 per share.	05 Jun 2024	100,000	0	-	6.4	644,840	Class A Common Stock
OppFi Inc (Class A)	David Vennettilli	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	100,000	100,000	-		0	Class A Common Stock
OppFi Inc (Class A)	David Vennettilli	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	100,000	44,238	-		-	Class A Common Units
BeiGene Ltd (ADR)	Chan Henry Lee	SVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	98,085	269,399 (0%)	0%		0	Ordinary Shares
Allogene Therapeutics Inc	Vicki L. Sato	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	95,541	95,541	-		-	Stock Option (Right to buy)
Allogene Therapeutics Inc	Franz Bernard Humer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	95,541	95,541	-		-	Stock Option (Right to buy)
InspireMD Inc	Paul S. Stuka	Director		05 Jun 2024	87,500	0	-		-	Series H Warrant (right to buy)
InspireMD Inc	Paul S. Stuka	Director		05 Jun 2024	87,500	336,034 (9%)	2%	1.4	120,986	Common Stock
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Carla C. Chavarria	SVP CHIEF HR OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	84,211	84,211	-		-	RESTRICTED STOCK UNITS
Knightscope Inc (Class A)	William Santana Li	Director, Chairman, CEO & President	Purchase of securities on an exchange or from another person at price $ 0.32 per share.	05 Jun 2024	83,333	83,333	-	0.3	26,350	Class A Common Stock
Microvision Inc	Brian V. Turner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	82,406	82,406	-		-	Restricted Stock Units
Microvision Inc	Simon Biddiscombe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	82,406	82,406	-		-	Restricted Stock Units
Microvision Inc	Robert P. Carlile	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	82,406	82,406	-		-	Restricted Stock Units
Microvision Inc	Mark B. Spitzer	Director		05 Jun 2024	82,406	82,406	-		-	Restricted Stock Units
Microvision Inc	Jeffrey A. Herbst	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	82,406	82,406	-		-	Restricted Stock Units
Microvision Inc	Jada Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	82,406	82,406	-		-	Restricted Stock Units
Sable Offshore Corp	Pipkin Phillip Gregory	Director	Sale of securities on an exchange or to another person at price $ 14.66 per share.	05 Jun 2024	82,238	85,540	-	14.7	1,205,461	Common Stock
Coinbase Global Inc (Class A)	Frederick R. Wilson	Director	Sale of securities on an exchange or to another person at price $ 250.09 per share.	05 Jun 2024	80,539	100,000	-	250.1	20,141,749	Class A Common Stock
Catalyst Pharma Inc Board Meeting	Gary Ingenito	Chief Med. & Reg. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.01 per share.	05 Jun 2024	80,000	131,391 (0%)	0%	4.0	320,800	Common stock, par value $0.001 per share
Catalyst Pharma Inc Board Meeting	Gary Ingenito	Chief Med. & Reg. Officer	Sale of securities on an exchange or to another person at price $ 16.16 per share.	05 Jun 2024	80,000	51,391 (0%)	0%	16.2	1,292,800	Common stock, par value $0.001 per share
Catalyst Pharma Inc Board Meeting	Gary Ingenito	Chief Med. & Reg. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	80,000	1,050,575	-		-	Options to purchase common stock
D-Wave Quantum Inc	Emil Michael	Director	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Jun 2024	78,552	2,488,676	-		-	Warrants
Prologis	Hamid R. Moghadam	Director, Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	75,619	1,057,422	-		-	LTIP Units
MeiraGTx Holdings PLC	Keith R. Harris	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	75,000	75,000	-		-	Restricted Share Units
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Kevin M. Connor	SVP GENERAL COUNSEL & SEC		05 Jun 2024	73,685	73,685	-		-	RESTRICTED STOCK UNITS
Dynatrace Inc	Rick M. Mcconnell	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.68 per share.	05 Jun 2024	73,567	782,491 (0%)	0%	46.7	3,434,108	Common Stock
Kyntra Bio Inc	James A. Schoeneck	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	70,000	70,000	-		-	Stock Option (Right to Buy)
Kyntra Bio Inc	Jeffrey L. Edwards	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	70,000	70,000	-		-	Stock Option (Right to Buy)
Kyntra Bio Inc	Maykin Ho	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	70,000	70,000	-		-	Stock Option (Right to Buy)
Kyntra Bio Inc	Aoife M. Brennan	Director		05 Jun 2024	70,000	70,000	-		-	Stock Option (Right to Buy)
Kyntra Bio Inc	Gerald Lema	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	70,000	70,000	-		-	Stock Option (Right to Buy)
Kyntra Bio Inc	Suzanne Blaug	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	70,000	70,000	-		-	Stock Option (Right to Buy)
Kyntra Bio Inc	Benjamin F. Cravatt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	70,000	70,000	-		-	Stock Option (Right to Buy)
HF Foods Grp Inc	Xi Lin	President and COO	Grant, award, or other acquisition of securities at price $ 3.55 per share.	05 Jun 2024	69,718	261,557 (0%)	0%	3.6	247,499	Common Stock
HF Foods Grp Inc	Xi Lin	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	69,718	69,718	-		-	Performance Stock Units
Rimini Street Inc	Steven M. Capelli	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	65,335	65,335	-		-	Restricted Stock Units
Rimini Street Inc	Jack L. Acosta	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	65,335	65,335	-		-	Restricted Stock Units
Rimini Street Inc	Robin P. Murray	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	65,335	65,335	-		-	Restricted Stock Units
Rimini Street Inc	Jay Snyder	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	65,335	65,335	-		-	Restricted Stock Units
Lucid Grp Inc	Eric Bach	SVP, Product & Chief Engineer		05 Jun 2024	64,804	2,118,227	-	2.8	184,691	Class A Common Stock
Oscar Health Inc (Class A)	R. Scott Blackley	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	62,500	125,000	-		-	Restricted Stock Units
Oscar Health Inc (Class A)	R. Scott Blackley	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	62,500	705,420	-		-	Class A Common Stock
Allogene Therapeutics Inc	Vicki L. Sato	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	61,475	162,575 (0%)	0%		0	Common Stock
Allogene Therapeutics Inc	Franz Bernard Humer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	61,475	316,728 (0%)	0%		0	Common Stock
Cue Biopharma Inc	Colin G. Sandercock	SVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	60,000	60,000	-		-	Stock Option (right to buy)
Cue Biopharma Inc	Kerri-Ann Millar	CHIEF FINANCIAL OFFICER		05 Jun 2024	60,000	60,000	-		-	Stock Option (right to buy)
AMD	Lisa T. Su	Director, Chair, President & CEO	Sale of securities on an exchange or to another person at price $ 165.30 per share.	05 Jun 2024	59,453	3,045,995 (0%)	0%	165.3	9,827,581	Common Stock
Compass Inc (Class A)	Frank D. Martell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	57,310	57,310	-		-	Restricted Stock Unit (RSU)
Compass Inc (Class A)	Pamela Thomas-Graham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	57,310	57,310	-		-	Restricted Stock Unit (RSU)
Compass Inc (Class A)	Steven J. Sordello	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	57,310	57,310	-		-	Restricted Stock Unit (RSU)
Compass Inc (Class A)	Charles E. Phillips	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	57,310	57,310	-		-	Restricted Stock Unit (RSU)
Compass Inc (Class A)	Allan Leinwand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	57,310	57,310	-		-	Restricted Stock Unit (RSU)
Compass Inc (Class A)	Dawanna Williams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	57,310	57,310	-		-	Restricted Stock Unit (RSU)
Compass Inc (Class A)	Josh N. McCarter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	57,310	57,310	-		-	Restricted Stock Unit (RSU)
Prologis	Hamid R. Moghadam	Director, Chairman & CEO	Other type of transaction at price $ 107.40 per share.	05 Jun 2024	57,007	925,407 (0%)	0%	107.4	6,122,552	Common Stock
Chegg Inc	Richard Sarnoff	Director		05 Jun 2024	54,347	314,089 (0%)	0%		0	Common Stock
Chegg Inc	Theodore E. Schlein	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	54,347	274,061 (0%)	0%		0	Common Stock
Chegg Inc	Marne Levine	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	54,347	120,365 (0%)	0%		0	Common Stock
Chegg Inc	John York	Director		05 Jun 2024	54,347	112,235 (0%)	0%		0	Common Stock
Chegg Inc	Renee Budig	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	54,347	113,715 (0%)	0%		0	Common Stock
Chegg Inc	Melanie Whelan	Director		05 Jun 2024	54,347	98,182 (0%)	0%		0	Common Stock
Chegg Inc	Paul J. Leblanc	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	54,347	85,513 (0%)	0%		0	Common Stock
Chegg Inc	Sarah R. Bond	Director		05 Jun 2024	54,347	89,383 (0%)	0%		0	Common Stock
Chegg Inc	Marcela Martin	Director		05 Jun 2024	54,347	87,518 (0%)	0%		0	Common Stock
HF Foods Grp Inc	Christine Chang	Chief Compliance Officer & GC	Grant, award, or other acquisition of securities at price $ 3.55 per share.	05 Jun 2024	52,817	166,091 (0%)	0%	3.5	187,500	Common Stock
HF Foods Grp Inc	Cindy Yao	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 3.55 per share.	05 Jun 2024	52,817	52,817 (0%)	0%	3.5	187,500	Common Stock
HF Foods Grp Inc	Christine Chang	Chief Administrative Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	52,817	52,817	-		-	Performance Stock Units
Monster Beverage 10-year high	Thomas J. Kelly	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 52.25 per share.	05 Jun 2024	52,502	74,924 (0%)	0%	52.3	2,743,230	Common Stock
Sagimet Biosciences Inc (Class A)	Beth C. Seidenberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	51,459	51,459	-		-	Stock Option (Right to Buy)
Sagimet Biosciences Inc (Class A)	Elizabeth Grammer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	51,459	51,459	-		-	Stock Option (Right to Buy)
Sagimet Biosciences Inc (Class A)	Merdad V. Parsey	Director		05 Jun 2024	51,459	51,459	-		-	Stock Option (Right to Buy)
Xeris Biopharma Holdings Inc	Jeffrey W. Sherman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	50,000	164,380 (0%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc	John H. Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	50,000	890,983 (3%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	50,000	107,500 (0%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc	John Schmid	Director		05 Jun 2024	50,000	113,159 (0%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc	Garheng Kong	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	50,000	164,144 (0%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc	B. J. Bormann	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	50,000	107,500 (0%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc	Dawn Halkuff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	50,000	107,500 (0%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc	Ricki Louise Fairley	Director		05 Jun 2024	50,000	135,000 (0%)	0%		0	Common Stock
Recursion Pharma Inc (Class A)	Christopher Gibson	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 9.00 per share.	05 Jun 2024	50,000	708,738	-	9	450,000	Class A Common Stock
Recursion Pharma Inc (Class A)	Christopher Gibson	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 8.42 per share.	05 Jun 2024	50,000	758,738	-	8.4	421,000	Class A Common Stock
Sunrun Inc	Lynn Jurich	Director	Sale of securities on an exchange or to another person at price $ 14.06 per share.	05 Jun 2024	50,000	1,395,297 (1%)	0%	14.1	702,890	Common Stock
Hillman Soln Corp	Aaron P. Jagdfeld	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	49,447	0	-		-	Stock Options
Hillman Soln Corp	Aaron P. Jagdfeld	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.07 per share.	05 Jun 2024	49,447	246,478	-	6.1	300,143	Common Stock
Hillman Soln Corp	Aaron P. Jagdfeld	Director	Sale of securities on an exchange or to another person at price $ 9.04 per share.	05 Jun 2024	49,447	197,031	-	9.0	447,001	Common Stock
OppFi Inc (Class A)	Theodore Schwartz	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	49,328	186,737	-		0	Class A Common Stock
OppFi Inc (Class A)	Greg Zeeman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	49,328	186,737	-		0	Class A Common Stock
OppFi Inc (Class A)	Christina M. Favilla	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	49,328	186,737	-		0	Class A Common Stock
OppFi Inc (Class A)	Jocelyn Moore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	49,328	122,221	-		0	Class A Common Stock
OppFi Inc (Class A)	David Vennettilli	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	49,328	143,825	-		0	Class A Common Stock
Dynatrace Inc	Bernd Greifeneder	EVP, Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	49,317	1,095,867 (0%)	0%		0	Common Stock
Dynatrace Inc	Daniel Zugelder	EVP, Chief Revenue Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	49,317	298,540 (0%)	0%		0	Common Stock
Inhibrx Biosciences Inc	Jon Faiz Kayyem	Director	Purchase of securities on an exchange or from another person at price $ 17.23 per share.	05 Jun 2024	49,284	1,142,145	-	17.2	849,163	Common Stock
AMD	Lisa T. Su	Director, Chair, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	47,577	0	-		-	Stock Option Grant
AMD	Lisa T. Su	Director, Chair, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.83 per share.	05 Jun 2024	47,577	3,144,807 (0%)	0%	12.8	610,413	Common Stock
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Chris A. Cox	SVP CHIEF ACCOUNTING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	47,369	47,369	-		-	RESTRICTED STOCK UNITS
PSQ Holdings Inc (Class A)	Kelly Loeffler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	46,440	46,400	-		-	Restricted Stock Unit
PSQ Holdings Inc (Class A)	Omeed Malik	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	46,440	46,400	-		-	Restricted Stock Unit
PSQ Holdings Inc (Class A)	Nick Ayers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	46,440	46,400	-		-	Restricted Stock Unit
PSQ Holdings Inc (Class A)	Blake Masters	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	46,440	46,400	-		-	Restricted Stock Unit
PSQ Holdings Inc (Class A)	Davis Pilot	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	46,440	46,400	-		-	Restricted Stock Unit
PSQ Holdings Inc (Class A)	James Rinn	Director		05 Jun 2024	46,440	46,400	-		-	Restricted Stock Unit
Savers Value Village Inc	Michael W. Maher	CFO & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	45,523	45,523	-		-	Option (Right to Purchase)
Vince Holding Corp	Michael J. Mardy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	45,455	108,408 (0%)	0%		0	Common Stock
Vince Holding Corp	Jerome Squire Griffith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	45,455	115,456 (0%)	0%		0	Common Stock
Vince Holding Corp	Eugenia M. Ulasewicz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	45,455	102,835 (0%)	0%		0	Common Stock
Vince Holding Corp	Robin S. Kramer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	45,455	87,217 (0%)	0%		0	Common Stock
Vince Holding Corp	David Stefko	Director, Interim CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	45,455	228,270 (1%)	0%		0	Common Stock
MeiraGTx Holdings PLC	Martin Indyk	Director		05 Jun 2024	45,000	45,000	-		-	Restricted Share Units
Ardelyx Inc	Laura Williams	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 7.12 per share.	05 Jun 2024	45,000	422,152 (0%)	0%	7.1	320,580	Common Stock
W & T Offshore Inc	William J. Williford	EVP & Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	45,000	90,000	-		-	Restricted Stock Units
W & T Offshore Inc	William J. Williford	EVP & Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	45,000	208,156 (0%)	0%		-	Common Stock
AMC Entertainment Holdings Inc (Class A) Results Board Meeting	Ellen Copaken	SVP MARKETING	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,737	44,737	-		-	RESTRICTED STOCK UNITS
Cogent Biosciences Inc	Arlene M. Morris	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,700	44,700	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Matthew E. Ros	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,700	44,700	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Karen Jean Ferrante	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,700	44,700	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Todd E. Shegog	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,700	44,700	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Peter Harwin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,700	44,700	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Christopher W. Cain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,700	44,700	-		-	Stock Option (Right to Buy)
Compass Inc (Class A)	Kalani Reelitz	Chief Financial Officer		05 Jun 2024	44,300	438,560	-	3.7	164,353	Class A Common Stock
Annexon Inc	Thomas G. Wiggans	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,000	44,000	-		-	Stock Option (Right to Buy)
Annexon Inc	Muneer A. Satter	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,000	44,000	-		-	Stock Option (Right to Buy)
Annexon Inc	William D. Waddill	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,000	44,000	-		-	Stock Option (Right to Buy)
Annexon Inc	Jung E. Choi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,000	44,000	-		-	Stock Option (Right to Buy)
Annexon Inc	William H. Carson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,000	44,000	-		-	Stock Option (Right to Buy)
Annexon Inc	Bettina M. Cockroft	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	44,000	44,000	-		-	Stock Option (Right to Buy)
Hayward Holdings Inc	P.	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 13.96 per share.	05 Jun 2024	42,857	522,799	-	14.0	598,352	Common Stock
Hayward Holdings Inc	P.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share.	05 Jun 2024	42,857	565,656	-	1.4	60,000	Common Stock
Hayward Holdings Inc	P.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	42,857	3,467,142	-		-	Stock Options (Right to Buy)
AMD	Lisa T. Su	Director, Chair, President & CEO	Sale of securities on an exchange or to another person at price $ 166.07 per share.	05 Jun 2024	42,028	3,003,967 (0%)	0%	166.1	6,979,590	Common Stock
W & T Offshore Inc	Tracy W. Krohn	Chairman, CEO & President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.14 per share.	05 Jun 2024	41,974	581,625 (0%)	0%	2.1	89,824	Common Stock
Lucid Grp Inc	Gagan Dhingra	VP of Acctng & Internal Ctrl*	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share.	05 Jun 2024	41,539	322,087	-	2.8	118,386	Class A Common Stock
D-Wave Quantum Inc	Emil Michael	Director	Sale of securities on an exchange or to another person at price $ 0.00 per share.	05 Jun 2024	41,216	2,567,228	-		-	Warrants
Rimini Street Inc	Steven M. Capelli	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	40,178	207,659 (0%)	0%		0	Common Stock
Rimini Street Inc	Steven M. Capelli	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	40,178	0	-		-	Restricted Stock Units
Rimini Street Inc	Jack L. Acosta	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	40,178	208,659 (0%)	0%		0	Common Stock
Rimini Street Inc	Jack L. Acosta	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	40,178	0	-		-	Restricted Stock Units
Rimini Street Inc	Robin P. Murray	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	40,178	0	-		-	Restricted Stock Units
Rimini Street Inc	Robin P. Murray	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	40,178	207,659 (0%)	0%		0	Common Stock
Rimini Street Inc	Jay Snyder	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	40,178	160,683 (0%)	0%		0	Common Stock
Rimini Street Inc	Jay Snyder	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	40,178	0	-		-	Restricted Stock Units
Cerus Corp	Daniel N. Swisher	Director		05 Jun 2024	40,000	147,045 (0%)	0%	5	200,000	Common Stock
Cerus Corp	Witney Frank	Director	Grant, award, or other acquisition of securities at price $ 5.00 per share.	05 Jun 2024	40,000	220,059 (0%)	0%	5	200,000	Common Stock
Cerus Corp	Eric H. Bjerkholt	Director	Grant, award, or other acquisition of securities at price $ 5.00 per share.	05 Jun 2024	40,000	182,133 (0%)	0%	5	200,000	Common Stock
Cerus Corp	Jami Dover Nachtsheim	Director	Grant, award, or other acquisition of securities at price $ 5.00 per share.	05 Jun 2024	40,000	148,362 (0%)	0%	5	200,000	Common Stock
Cerus Corp	Gail Gaumer Schulze	Director		05 Jun 2024	40,000	163,420 (0%)	0%	5	200,000	Common Stock
Cerus Corp	Timothy L. Moore	Director	Grant, award, or other acquisition of securities at price $ 5.00 per share.	05 Jun 2024	40,000	145,073 (0%)	0%	5	200,000	Common Stock
Cerus Corp	Ann Lucena	Director	Grant, award, or other acquisition of securities at price $ 5.00 per share.	05 Jun 2024	40,000	112,284 (0%)	0%	5	200,000	Common Stock
Cerus Corp	Hua Shan	Director	Grant, award, or other acquisition of securities at price $ 5.00 per share.	05 Jun 2024	40,000	72,386 (0%)	0%	5	200,000	Common Stock
Dare Bioscience Inc	Robin J. Steele	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
Dare Bioscience Inc	William H. Rastetter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
Dare Bioscience Inc	Gregory W. Matz	Director		05 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
Dare Bioscience Inc	Susan L. Kelley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
Dare Bioscience Inc	Jessica D. Grossman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
Ondas Holdings Inc	Richard M. Cohen	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	92,467	-		0	Common Stock
Ondas Holdings Inc	Richard M. Cohen	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	117,382	-		0	Common Stock
Ondas Holdings Inc	Richard M. Cohen	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	118,420	-		-	Restricted Stock Units
Ondas Holdings Inc	Richard M. Cohen	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	78,946	-		-	Restricted Stock Units
Ondas Holdings Inc	Randall P. Seidl	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	118,420	-		-	Restricted Stock Units
Ondas Holdings Inc	Randall P. Seidl	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	82,749	-		0	Common Stock
Ondas Holdings Inc	Randall P. Seidl	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	109,709	-		0	Common Stock
Ondas Holdings Inc	Randall P. Seidl	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	78,946	-		-	Restricted Stock Units
Ondas Holdings Inc	Jaspreet K. Sood	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	81,477	-		0	Common Stock
Ondas Holdings Inc	Jaspreet K. Sood	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	104,265	-		0	Common Stock
Ondas Holdings Inc	Jaspreet K. Sood	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	118,420	-		-	Restricted Stock Units
Ondas Holdings Inc	Jaspreet K. Sood	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	39,474	78,946	-		-	Restricted Stock Units
Fortinet	Keith Jensen	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 59.22 per share.	05 Jun 2024	39,049	23,364 (0%)	0%	59.2	2,312,482	Common Stock
Abeona Therapeutics Inc	Vishwas Seshadri	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share.	05 Jun 2024	38,621	498,936 (0%)	0%	4.5	174,567	Common Stock
ElectroCore Inc	Daniel S. Goldberger	Director, Chief Executive Officer		05 Jun 2024	38,505	249,565 (0%)	0%	6.4	247,587	Common Stock
ElectroCore Inc	Thomas J. Errico	Director	Grant, award, or other acquisition of securities at price $ 6.43 per share.	05 Jun 2024	38,505	228,818 (0%)	0%	6.4	247,587	Common Stock
BARK Inc (Class A)	Matt Meeker	Director, Executive Chairman	Purchase of securities on an exchange or from another person at price $ 1.39 per share.	05 Jun 2024	38,461	9,980,783	-	1.4	53,530	Common Stock
Cytek BioSciences Inc	Michael Holder	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,878	37,878	-		-	Stock Option (right to buy)
Tango Therapeutics Inc	Alexis A. Borisy	Director		05 Jun 2024	37,500	37,500	-		-	Stock Option (Right to Buy)
Tango Therapeutics Inc	Lesley Ann Calhoun	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,500	37,500	-		-	Stock Option (Right to Buy)
Tango Therapeutics Inc	Malte Peters	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,500	37,500	-		-	Stock Option (Right to Buy)
Tango Therapeutics Inc	Mace Rothenberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,500	37,500	-		-	Stock Option (Right to Buy)
Plug Power Inc	Gary K. Willis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	37,375	-		-	Stock Option (Right to Buy)
Plug Power Inc	Gary K. Willis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	493,905 (0%)	0%		0	Common Stock
Plug Power Inc	George C. Mcnamee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	676,947 (0%)	0%		0	Common Stock
Plug Power Inc	George C. Mcnamee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	37,375	-		-	Stock Option (Right to Buy)
Plug Power Inc	Mark J. Bonney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	37,375	-		-	Stock Option (Right to Buy)
Plug Power Inc	Mark J. Bonney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	48,339 (0%)	0%		0	Common Stock
Plug Power Inc	Maureen O. Helmer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	193,564 (0%)	0%		0	Common Stock
Plug Power Inc	Maureen O. Helmer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	37,375	-		-	Stock Option (Right to Buy)
Plug Power Inc	Patrick Joggerst	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	46,608 (0%)	0%		0	Common Stock
Plug Power Inc	Patrick Joggerst	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	37,375	-		-	Stock Option (Right to Buy)
Plug Power Inc	Gregory L. Kenausis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	312,790 (0%)	0%		0	Common Stock
Plug Power Inc	Gregory L. Kenausis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	37,375	-		-	Stock Option (Right to Buy)
Plug Power Inc	Kavita Mahtani	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	70,338 (0%)	0%		0	Common Stock
Plug Power Inc	Kavita Mahtani	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	37,375	37,375	-		-	Stock Option (Right to Buy)
Dynatrace Inc	Matthias Dollentz-Scharer	EVP, Chief Customer Officer		05 Jun 2024	36,452	141,533 (0%)	0%		0	Common Stock
VerifyMe Inc	Arthur B. Laffer	Director		05 Jun 2024	35,000	314,910	-		0	Common Stock, par value $0.001
VerifyMe Inc	Marshall S. Geller	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	35,000	87,000	-		0	Common Stock, par value $0.001
VerifyMe Inc	Scott N. Greenberg	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	35,000	249,572	-		0	Common Stock, par value $0.001
VerifyMe Inc	Howard Goldberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	35,000	338,662	-		0	Common Stock, par value $0.001
VerifyMe Inc	David Edmonds	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	35,000	35,000	-		-	Restricted Stock Units
Floor & Decor Holdings Inc (Class A)	Thomas V. Taylor	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.99 per share.	05 Jun 2024	34,198	202,584 (0%)	0%	10.0	341,638	Class A common stock, par value $0.001
Floor & Decor Holdings Inc (Class A)	Thomas V. Taylor	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	34,198	34,199	-		-	Stock Option (right to buy)
Floor & Decor Holdings Inc (Class A)	Thomas V. Taylor	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 120.00 per share.	05 Jun 2024	34,198	168,386 (0%)	0%	120	4,103,760	Class A common stock, par value $0.001
BeiGene Ltd (ADR)	Anthony C. Hooper	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	34,151	34,151	-		-	Share Option (Right to Buy)
BeiGene Ltd (ADR)	Olivier Raymond Brandicourt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	34,151	34,151	-		-	Share Option (Right to Buy)
BeiGene Ltd (ADR)	Donald W. Glazer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	34,151	34,151	-		-	Share Option (Right to Buy)
BeiGene Ltd (ADR)	Qingqing Yi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	34,151	34,151	-		-	Share Option (Right to Buy)
BeiGene Ltd (ADR)	Corazon Dating Sanders	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	34,151	34,151	-		-	Share Option (Right to Buy)
BeiGene Ltd (ADR)	Alessandro Riva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	34,151	34,151	-		-	Share Option (Right to Buy)
BeiGene Ltd (ADR)	Margaret Dugan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	34,151	34,151	-		-	Share Option (Right to Buy)
Spire Global Inc (Class A)	Dirk Carsten Hoke	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	33,901	33,901	-		-	Stock Option (right to buy)
Rapid7 Inc	Christina Luconi	Chief People Officer		05 Jun 2024	33,795	92,487 (0%)	0%	35.9	1,214,930	COMMON STOCK
Aviat Networks Inc	Michael Connaway	SVP & Chief Financial Officer		05 Jun 2024	32,489	32,489 (0%)	0%		0	Common Stock
AFC Gamma Inc	Leonard M. Tannenbaum	Director, Executive Chairman; CIO, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 12.09 per share.	05 Jun 2024	31,335	3,775,973	-	12.1	378,840	Common Stock
Oscar Health Inc (Class A)	Alessandrea C. Quane	EVP, Chief Insurance Officer		05 Jun 2024	31,250	62,500	-		-	Restricted Stock Units
Oscar Health Inc (Class A)	Alessandrea C. Quane	EVP, Chief Insurance Officer		05 Jun 2024	31,250	267,929	-		-	Class A Common Stock
Fathom Holdings Inc Results Board Meeting	Scott N. Flanders	Director	Purchase of securities on an exchange or from another person at price $ 1.83 per share.	05 Jun 2024	31,115	655,378	-	1.8	56,975	Common Stock
Kosmos Energy Ltd	Roy Alexander Franklin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	30,196	98,872 (0%)	0%		0	Common Stock
Kosmos Energy Ltd	John Grant	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	30,196	58,119 (0%)	0%		0	Common Stock
AFC Gamma Inc	Leonard M. Tannenbaum	Director, Executive Chairman; CIO, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 11.95 per share.	05 Jun 2024	30,000	159,217	-	12.0	358,500	Common Stock
MeiraGTx Holdings PLC	Keith R. Harris	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	30,000	0	-		-	Restricted Share Units
MeiraGTx Holdings PLC	Keith R. Harris	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	30,000	50,000 (0%)	0%		-	Ordinary Shares
Oscar Health Inc (Class A)	R. Scott Blackley	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 19.58 per share.	05 Jun 2024	29,978	675,442	-	19.6	586,969	Class A Common Stock
Mimedx Grp Inc	Dorothy E. Puhy	Director	Grant, award, or other acquisition of securities at price $ 7.26 per share.	05 Jun 2024	28,988	28,988 (0%)	0%	7.3	210,453	Common Stock
Mimedx Grp Inc	Tiffany P. Olson	Director	Grant, award, or other acquisition of securities at price $ 7.26 per share.	05 Jun 2024	28,988	28,988 (0%)	0%	7.3	210,453	Common Stock
IPG Photonics Corp Acquisition	Mark Milton Gitin	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	28,791	28,791 (0%)	0%		0	Common Stock
Figs Inc (Class A)	Alan G. Lafley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	28,143	65,096	-		0	Class A Common Stock
Figs Inc (Class A)	Jeffrey A. Wilke	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	28,143	182,709	-		0	Class A Common Stock
Figs Inc (Class A)	Mario J. Marte	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	28,143	41,178	-		0	Class A Common Stock
Figs Inc (Class A)	Sheila Antrum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	28,143	70,795	-		0	Class A Common Stock
Figs Inc (Class A)	John Martin Willhite	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	28,143	3,218,227	-		0	Class A Common Stock
Figs Inc (Class A)	Kenneth Lin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	28,143	116,837	-		0	Class A Common Stock
Tango Therapeutics Inc	John B. Ketchum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	28,125	28,125	-		-	Stock Option (Right to Buy)
AFC Gamma Inc	Leonard M. Tannenbaum	Director, Executive Chairman; CIO, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 11.98 per share.	05 Jun 2024	27,500	3,803,473	-	12.0	329,450	Common Stock
Rumble Inc (Class A)	Robert Arsov	Director		05 Jun 2024	27,500	15,053,902	-	6.1	167,200	Class A Common Stock, par value $0.0001 per share
Rumble Inc (Class A)	Robert Arsov	Director		05 Jun 2024	27,500	15,083,902	-	6.1	166,925	Class A Common Stock, par value $0.0001 per share
Granite Point Mortgage Trust Inc	Stephen G. Kasnet	Director	Sale of securities on an exchange or to another person at price $ 3.08 per share.	05 Jun 2024	27,027	121,066 (0%)	0%	3.1	83,162	Common Stock
Quince Therapeutics Inc	Una S. Ryan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	27,000	27,000	-		-	Employee Stock Option (right to buy)
Quince Therapeutics Inc	Luca Benatti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	27,000	27,000	-		-	Employee Stock Option (right to buy)
Quince Therapeutics Inc	Christopher J. Senner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	27,000	27,000	-		-	Employee Stock Option (right to buy)
Quince Therapeutics Inc	David A. Lamond	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	27,000	27,000	-		-	Employee Stock Option (right to buy)
Quince Therapeutics Inc	Margaret McLoughlin A.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	27,000	27,000	-		-	Employee Stock Option (right to buy)
Quince Therapeutics Inc	June Bray	Director		05 Jun 2024	27,000	27,000	-		-	Employee Stock Option (right to buy)
Dynatrace Inc	Daniel Zugelder	EVP, Chief Revenue Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.68 per share.	05 Jun 2024	26,955	271,585 (0%)	0%	46.7	1,258,259	Common Stock
Warner Bros. (Class A)	Debra L. Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,700	59,151 (0%)	0%		0	Series A Common Stock
Warner Bros. (Class A)	Geoffrey Y. Yang	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,700	133,871 (0%)	0%		0	Series A Common Stock
Warner Bros. (Class A)	Kenneth W. Lowe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,700	1,077,041 (0%)	0%		0	Series A Common Stock
Warner Bros. (Class A)	Paula A. Price	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,700	59,151 (0%)	0%		0	Series A Common Stock
Warner Bros. (Class A)	Paul Alan Gould	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,700	820,357 (0%)	0%		0	Series A Common Stock
Warner Bros. (Class A)	Samuel A. Di Piazza	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,700	114,652 (0%)	0%		0	Series A Common Stock
Warner Bros. (Class A)	John C. Malone	Director		05 Jun 2024	26,700	9,636,170 (6%)	0%		0	Series A Common Stock
Warner Bros. (Class A)	Fazal F. Merchant	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,700	106,539 (0%)	0%		0	Series A Common Stock
Warner Bros. (Class A)	Richard W. Fisher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,700	61,570 (0%)	0%		0	Series A Common Stock
Warner Bros. (Class A)	Li Haslett Chen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,700	59,151 (0%)	0%		0	Series A Common Stock
Adicet Bio Inc	Carl L. Gordon	Director, Ten Percent Owner		05 Jun 2024	26,400	26,400	-		-	Stock Option (Right to Buy)
Adicet Bio Inc	Michael Glen Kauffman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,400	26,400	-		-	Stock Option (Right to Buy)
Adicet Bio Inc	Steve Dubin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,400	26,400	-		-	Stock Option (Right to Buy)
Adicet Bio Inc	Aya Jakobovits	Director		05 Jun 2024	26,400	26,400	-		-	Stock Option (Right to Buy)
Adicet Bio Inc	Jeffrey A. Chodakewitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,400	26,400	-		-	Stock Option (Right to Buy)
Adicet Bio Inc	Katie Peng	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,400	26,400	-		-	Stock Option (Right to Buy)
Cytek BioSciences Inc	Michael Holder	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,178	26,178	-		-	Restricted Stock Units
Kura Oncology Inc	Carol A. Schafer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,000	26,000	-		-	Option to purchase common stock
Kura Oncology Inc	Faheem Hasnain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,000	26,000	-		-	Option to purchase common stock
Kura Oncology Inc	Mary T. Szela	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,000	26,000	-		-	Option to purchase common stock
Kura Oncology Inc	Thomas R. Malley	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,000	26,000	-		-	Option to purchase common stock
Kura Oncology Inc	Helen Collins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,000	26,000	-		-	Option to purchase common stock
Kura Oncology Inc	Diane L. Parks	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	26,000	26,000	-		-	Option to purchase common stock
Vital Farms Inc	Matthew O’Hayer	Director, EXECUTIVE CHAIRPERSON, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 43.65 per share.	05 Jun 2024	25,926	7,328,421	-	43.7	1,131,670	Common Stock
NeuroOne Medical Tech Corp	Mark Christianson	Business Development Director	Sale of securities on an exchange or to another person at price $ 0.88 per share.	05 Jun 2024	25,800	297,224	-	0.9	22,663	Common Stock
Agios Pharma Inc	Brian Goff	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	25,527	79,307 (0%)	0%		0	Common stock
Agios Pharma Inc	Brian Goff	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	25,527	76,583	-		-	Performance share units
Boston Omaha Corp (Class A)	Adam K. Peterson	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 14.37 per share.	05 Jun 2024	25,300	6,718,218 (30%)	0%	14.4	363,561	Class A Common Stock, par value $0.001 per share
Global Business Travel Grp Inc (Class A)	Kathleen A. Winters	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	25,039	66,281	-		0	Class A Common Stock
Global Business Travel Grp Inc (Class A)	James Peter Bush	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	25,039	83,781	-		0	Class A Common Stock
Global Business Travel Grp Inc (Class A)	Raymond Donald Joabar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	25,039	66,281	-		0	Class A Common Stock
Global Business Travel Grp Inc (Class A)	Susan F. Ward	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	25,039	66,281	-		0	Class A Common Stock
Global Business Travel Grp Inc (Class A)	Eric M. Hart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	25,039	66,281	-		0	Class A Common Stock
Global Business Travel Grp Inc (Class A)	Mohammed Saif S.S. Al-Sowaidi	Director		05 Jun 2024	25,039	66,281	-		0	Class A Common Stock
Global Business Travel Grp Inc (Class A)	Alexander Drummond	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	25,039	25,039	-		0	Class A Common Stock
Healthequity Inc	Stephen D. Neeleman	Director, FOUNDER AND VICE CHAIRMAN	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.00 per share.	05 Jun 2024	25,036	115,551 (0%)	0%	14	350,504	Common Stock
Healthequity Inc	Stephen D. Neeleman	Director, FOUNDER AND VICE CHAIRMAN	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	25,036	44,564	-		-	Stock Option (right to buy)
Healthequity Inc	Stephen D. Neeleman	Director, FOUNDER AND VICE CHAIRMAN	Sale of securities on an exchange or to another person at price $ 85.06 per share.	05 Jun 2024	25,036	90,515 (0%)	0%	85.1	2,129,452	Common Stock
Recursion Pharma Inc (Class A)	Christopher Gibson	Director, Chief Executive Officer		05 Jun 2024	25,000	833,738	-		0	Class A Common Stock
Recursion Pharma Inc (Class A)	Christopher Gibson	Director, Chief Executive Officer		05 Jun 2024	25,000	6,401,700	-		-	Class B Common Stock
Recursion Pharma Inc (Class A)	Christopher Gibson	Director, Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	05 Jun 2024	25,000	808,738	-		0	Class A Common Stock
Dynatrace Inc	Bernd Greifeneder	EVP, Chief Technology Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.68 per share.	05 Jun 2024	24,695	1,071,633 (0%)	0%	46.7	1,152,763	Common Stock
MFA Fin Inc	Laurie S. Goodman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,628	119,033	-		-	Restricted Stock Units
BeiGene Ltd (ADR)	Titus B. Ball	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,427	47,905 (0%)	0%		0	Ordinary Shares
FVCBankcorp Inc Results	L. Burwell Gunn	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.56 per share.	05 Jun 2024	24,413	76,556 (0%)	0%	5.6	135,744	Common Stock
FVCBankcorp Inc Results	L. Burwell Gunn	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	24,413	24,413	-		-	Stock Options
Voyager Therapeutics Inc	James A. Geraghty	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Voyager Therapeutics Inc	George A. Scangos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Voyager Therapeutics Inc	Michael J. Higgins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Voyager Therapeutics Inc	Glenn F. Pierce	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Voyager Therapeutics Inc	Catherine J. Mackey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Voyager Therapeutics Inc	Steven E. Hyman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Voyager Therapeutics Inc	Grace E. Colon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Voyager Therapeutics Inc	Nancy Vitale	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Voyager Therapeutics Inc	Jude Onyia	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	24,000	24,000	-		-	Stock Option (Right to Buy)
Monster Beverage 10-year high	Thomas J. Kelly	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jun 2024	24,000	0	-		-	Employee Stock Option (right to buy)
Monster Beverage 10-year high	Thomas J. Kelly	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.20 per share.	05 Jun 2024	24,000	99,678 (0%)	0%	31.2	748,800	Common Stock
Mimedx Grp Inc	Cato T. Laurencin	Director	Grant, award, or other acquisition of securities at price $ 7.26 per share.	05 Jun 2024	23,190	153,314 (0%)	0%	7.3	168,359	Common Stock
Mimedx Grp Inc	M. Kathleen Behrens Wilsey	Director	Grant, award, or other acquisition of securities at price $ 7.26 per share.	05 Jun 2024	23,190	184,162 (0%)	0%	7.3	168,359	Common Stock
Mimedx Grp Inc	William A. Hawkins	Director	Grant, award, or other acquisition of securities at price $ 7.26 per share.	05 Jun 2024	23,190	175,409 (0%)	0%	7.3	168,359	Common Stock
Mimedx Grp Inc	James L. Bierman	Director	Grant, award, or other acquisition of securities at price $ 7.26 per share.	05 Jun 2024	23,190	184,162 (0%)	0%	7.3	168,359	Common Stock
Mimedx Grp Inc	K. Todd Newton	Director	Grant, award, or other acquisition of securities at price $ 7.26 per share.	05 Jun 2024	23,190	384,162 (0%)	0%	7.3	168,359	Common Stock
OppFi Inc (Class A)	Jocelyn Moore	Director	Sale of securities on an exchange or to another person at price $ 6.70 per share.	05 Jun 2024	23,149	99,072	-	6.7	155,013	Class A Common Stock
Beam Therapeutics Inc	Graham K. Cooper	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	23,114	23,114	-		-	Stock Option (Right to Buy)
Beam Therapeutics Inc	John M. Maraganore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	23,114	23,114	-		-	Stock Option (Right to Buy)
Beam Therapeutics Inc	Mark C. Fishman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	23,114	23,114	-		-	Stock Option (Right to Buy)
Beam Therapeutics Inc	Kathleen E. Walsh	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	23,114	23,114	-		-	Stock Option (Right to Buy)
Beam Therapeutics Inc	Christi Shaw	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	23,114	23,114	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Jun 05, 2024

Monitor US insider transactions and discover insider buying and selling of stocks on Jun 05, 2024.

Screeners based on Insider Trading parameters